Cargando…
Nrf2-Inducers Counteract Neurodegeneration in Frataxin-Silenced Motor Neurons: Disclosing New Therapeutic Targets for Friedreich’s Ataxia
Oxidative stress is actively involved in Friedreich’s Ataxia (FA), thus pharmacological targeting of the antioxidant machinery may have therapeutic value. Here, we analyzed the relevance of the antioxidant phase II response mediated by the transcription factor Nrf2 on frataxin-deficient cultured mot...
Autores principales: | Petrillo, Sara, Piermarini, Emanuela, Pastore, Anna, Vasco, Gessica, Schirinzi, Tommaso, Carrozzo, Rosalba, Bertini, Enrico, Piemonte, Fiorella |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5666854/ https://www.ncbi.nlm.nih.gov/pubmed/29057804 http://dx.doi.org/10.3390/ijms18102173 |
Ejemplares similares
-
The Nrf2 induction prevents ferroptosis in Friedreich's Ataxia
por: La Rosa, Piergiorgio, et al.
Publicado: (2020) -
Frataxin Silencing Inactivates Mitochondrial Complex I in NSC34 Motoneuronal Cells and Alters Glutathione Homeostasis
por: Carletti, Barbara, et al.
Publicado: (2014) -
Targeting NRF2 for the Treatment of Friedreich’s Ataxia: A Comparison among Drugs
por: Petrillo, Sara, et al.
Publicado: (2019) -
Neurodegeneration in Friedreich's Ataxia: From Defective Frataxin to Oxidative Stress
por: Gomes, Cláudio M., et al.
Publicado: (2013) -
Friedreich ataxia in COVID-19 time: current impact and future possibilities
por: Schirinzi, Tommaso, et al.
Publicado: (2021)